AuthorisedTherapeutic exploratory (Phase II)Interventional

FINACCESS - Finnish National Study for Early Access to Cancer Therapies

The FINACCESS study is a research project aiming to understand how effective new cancer medicines are and what side effects they might have. This study is open to adult patients with various types of cancer. The researchers are particularly interested in treatments that are either already approved by major health bodies like the EMA and FDA, or are close to being approved and have been shown to be safe enough for testing. They also want to learn how these new drugs affect the cancer cells in people, by looking at things like genes and other markers. The main goal is to find better ways to treat cancer and help patients access promising new therapies sooner, while making sure they are safe.

At a glance

Status

Authorised

Phase

Therapeutic exploratory (Phase II)

Sponsor

HUS-yhtymae

Enrolment target

1,500

Start

08 May 2026

Cancer

What is this study about?

The FINACCESS study is a significant research project designed to explore how new cancer treatments work in patients. Many new medicines are developed for cancer, and this study aims to see how effective they are at shrinking or stopping cancer growth, and what side effects they might cause. It focuses on medicines that are either newly approved or are currently being reviewed by big medical organisations like the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) – these are the groups that decide if medicines are safe and work well.

Think of it like this: for a new car to be sold, it needs to pass safety tests and show it performs well. It's similar for new medicines. This study is a crucial step in evaluating these promising cancer therapies directly in patients. By taking part, patients could gain early access to treatments that are not yet widely available, and also help scientists understand more about how cancer responds to different drugs.

Beyond just looking at how the treatment works, the study also aims to understand *why* it works (or doesn't work) in certain people. Researchers will be looking at special markers in blood or tumour samples to see how a person's cancer reacts to the medicine at a very detailed level. This helps them learn more about how cancer grows and how it might become resistant to treatments, which can lead to even better medicines in the future.

Key takeaways

Exploring new cancer treatments for adults.
Investigating both effectiveness and side effects.
Potential for early access to promising therapies.
Aims to understand how drugs work at a detailed level.
Open to adults aged 18 and over with cancer.

Who may be eligible?

This study is open to adults who are 18 years old or older. There is no upper age limit, meaning older adults can also take part.

It's for people with a diagnosis of cancer. The study is designed to include a wide range of cancer types, so your specific cancer diagnosis would be assessed by the study team.

Both men and women are welcome to participate in this research. The study team will check other health details to make sure the treatment would be suitable and safe for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Do you have a diagnosis of cancer?
Are you willing to have regular hospital visits and tests?
Are you able to speak with the study doctors about your health?

Answer every question to see your result.

What does participation involve?

If you decide to take part in the FINACCESS study, you would first have some checks to make sure the study medicine might be suitable for you. This involves tests like blood sampling and possibly scans. You would be given a study medicine, and then visit the clinic regularly. These visits are to monitor how you are responding to the treatment, check for any side effects, and perform any necessary tests. The duration of your involvement could vary depending on how you respond to the treatment and the specific drug you're given. There will also be follow-up appointments after you stop the treatment to monitor your health.

Potential risks and benefits

Taking part in any medical study has potential benefits and risks. A possible benefit of this study is early access to new cancer treatments that are not yet widely available. These treatments might help your cancer in ways that current standard treatments cannot. However, there are also potential risks, including side effects from the study medicine, which could be mild or more serious. The study team will explain all known potential side effects to you. It's very important to remember that you have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

—
Unverified
Finland

Common questions

What kind of medicines are being tested?

Medicines that are new, either recently approved or close to approval by major health bodies, are being tested.

Will I know if I'm getting an active drug or a placebo?

This study is testing active anti-cancer drugs, so you would be receiving one of these active treatments if you participate.

How long will I be in the study?

The length of time you're in the study will depend on your individual response to the treatment and the study plan, but you will have regular check-ups.

What happens if I experience side effects?

The study team will closely monitor you for any side effects and provide care and support to manage them.

Do I have to pay to be in the study?

No, you do not have to pay to participate in the study. All study-related treatments and tests are provided free of charge.